dc.contributor.author |
Stefan, Norbert |
|
dc.contributor.author |
Kantartzis, Konstantinos |
|
dc.contributor.author |
Machann, Jürgen |
|
dc.contributor.author |
Häring, Hans-Ulrich |
|
dc.date.accessioned |
2014-10-06T13:46:09Z |
|
dc.date.available |
2014-10-06T13:46:09Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
2213-8587 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/56763 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/S2213-8587(13)70170-0 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Inhibition of 11 beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140813180100_00582 |
de_DE |
utue.publikation.seiten |
406-416 |
de_DE |
utue.personen.roh |
Stefan, Norbert |
|
utue.personen.roh |
Ramsauer, Markus |
|
utue.personen.roh |
Jordan, Paul |
|
utue.personen.roh |
Nowotny, Bettina |
|
utue.personen.roh |
Kantartzis, Konstantinos |
|
utue.personen.roh |
Machann, Juergen |
|
utue.personen.roh |
Hwang, Jong-Hee |
|
utue.personen.roh |
Nowotny, Peter |
|
utue.personen.roh |
Kahl, Sabine |
|
utue.personen.roh |
Harreiter, Juergen |
|
utue.personen.roh |
Hornemann, Silke |
|
utue.personen.roh |
Sanyal, Arun J. |
|
utue.personen.roh |
Stewart, Paul M. |
|
utue.personen.roh |
Pfeiffer, Andreas F. |
|
utue.personen.roh |
Kautzky-Willer, Alexandra |
|
utue.personen.roh |
Roden, Michael |
|
utue.personen.roh |
Haering, Hans-Ulrich |
|
utue.personen.roh |
Fuerst-Recktenwald, Sabine |
|
dcterms.isPartOf.ZSTitelID |
Lancet Diabetes & Endocrinology |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
2 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |